Healthcare BPO Market by Outsourcing Models, Provider, Payer, Life Science and Region - Global Forecasts to 2026
July 26, 2021 09:23 ET
|
Research and Markets
Dublin, July 26, 2021 (GLOBE NEWSWIRE) -- The "Global Healthcare BPO Market by Outsourcing Models, Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Life Science...
uniQure Announces Enrollment of First Two Patients in Second Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
June 16, 2021 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, June 16, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Global Clinical Trials Market Analysis Report 2021: Phase III Clinical Trials Dominated the Market with a Share of 53.2% in 2020 - Forecast to 2028
June 04, 2021 07:33 ET
|
Research and Markets
Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional,...
Neovasc Announces First Patient Enrollment in COSIMA Trial
May 10, 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled...
World Virtual Clinical Trial Service Providers Market 2020-2025, by Type of Therapeutic Area, End-Users, Phase of Development and Key Geographies
April 27, 2021 08:38 ET
|
Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trial Service Providers Market by Type of Therapeutic Area, End-Users, Phase of Development (Phase I, Phase II, Phase III and Phase...
Data Science Impacting the Pharmaceutical Industry, 2020 Report: Focus on Clinical Trials - Data Science-driven Patient Selection & FDA Accelerated Data Sharing has Opened Many Opportunities
February 10, 2021 04:18 ET
|
Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "Data Science Impacting the Pharmaceutical Industry Part II: Clinical Trial Applications" report has been added to ResearchAndMarkets.com's offering. ...
Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial
January 19, 2021 08:30 ET
|
Phathom Pharmaceuticals
Topline results expected in second quarter of 2021NDA submission for H. pylori expected in second half of 2021 FLORHAM PARK, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals,...
American BriVision Announces Completed Patient Enrollment in Clinical Trial at UCSF for Treatment of Adult ADHD
June 15, 2020 09:00 ET
|
American BriVision Holding Corporation
Patient enrollment has been completed for a Phase II Part I clinical trial at the University of California, San Francisco (UCSF) Medical Center Primary objective of Phase II Part I clinical trial is...
N.M. MEDICAL CANNABIS PROGRAM SEES RECORD PATIENT GROWTH
July 25, 2017 15:00 ET
|
Ultra Health
Albuquerque, NM, July 25, 2017 (GLOBE NEWSWIRE) -- The New Mexico Medical Cannabis Program’s patient enrollment has seen its fastest growth yet, climbing by 15,357 patients or 53 percent in the...
Achillion Announces That Janssen Has Initiated a Phase 2a Study to Evaluate the Combination of AL-335, Odalasvir (ACH-3102), and Simeprevir for the Treatment of Genotype 1 Chronic HCV
October 16, 2015 06:05 ET
|
Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Oct. 16, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Alios Biopharma Inc., part of the Janssen Pharmaceutical Companies (Janssen)...